Wearable Device to Promote CPAP Adherence in Obstructive Sleep Apnea (OSA) Patients
Key facts
- Who runs it
- Ramathibodi Hospital
- Where
- Thailand1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 80 people, planned
- Started
- 6 Jan 2026
- Planned end
- 30 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- garmin vivoactive 5 with self-monitoring data
- Garmin vivoactive 5 without self-monitoring data
- Record updated
- 30 January 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adult patients (≥ 19 yr of age) with moderate to severe OSA (AHI ≥ 15 events/hr at the sleep clinic in Ramathibodi hospital
- Study after EC approval to March, 2026
- Patients with OSA who are prescribed CPAP therapy and accepted a trial of therapy
Who cannot take part
- Patients had been previously used CPAP for treatment of OSA
- Patients had active cardiovascular, pulmonary, psychiatric disease, and epilepsy
- Patients deny to provide an informed consent
- Patients have a problem to use a wearable device or watch
- Patients had used any smartwatch before
- Patients do not have a smart phone
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this study type: clinical trial is to evaluate adherence for CPAP used with wearable device in OSA patients comparing with controlled group; could include any of the following: adult patients (≥ 19 yr of age) with moderate to severe OSA (AHI ≥ 15 events/hr by polysomnography (PSG), according to the American Academy of Sleep Medicine, diagnosed at the sleep clinic in Ramathibodi hospital, patients with OSA who are first time to prescribed CPAP treatment and in the waiting process for their machine. The main question it aims to answer is: Could a wearable device help increase the adherence of CPAP in obstructive sleep apnea patients?
Read full original descriptionShow less
Primary outcome is adherence for CPAP: time usage per day(min) and % usage > 4 hours
Secondary outcome are access sleepiness and quality of sleep by questionnaire (ESS and PSQI) in Thai version, the correlation between wearable-derived and CPAP data: Total sleep time(min), sleep stage (light, deep and REM), and health information: heart rate, oxygen saturation, stress, sleep score and step counting
If there is a comparison group: Researchers will compare wearable group and control group to see the effect of wearable to increase adherence of CPAP used.
Participants will
* Divide into two group by randomization using 4 block randomization * In wearable group, the participants will receive wearable and download application, they allow to access all the time * In control group, the participants will receive wearable and download application, but they will not allow to access until they come to hospital for follow up at the end of the study
The 2 groups in the trial
- Wearable groupTreatment being tested
Standard care of CPAP with Garmin vivoactive 5 with self-monitoring data (Patients can access the data by themselves)
Treatment: garmin vivoactive 5 with self-monitoring data
- Control groupSham treatment, for comparison
Standard care of CPAP with Garmin vivoactive 5 no self-monitoring data (Patients cannot access the data by themselves)
Treatment: Garmin vivoactive 5 without self-monitoring data
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Efficacy of Wearable Device to Promote CPAP Adherence in Patients With Obstructive Sleep Apnea (OSA); A Randomized Controlled Trial
- Record updated
- 30 January 2026